ro 31-8220 has been researched along with Malignant Melanoma in 3 studies
Ro 31-8220: a protein kinase C inhibitor
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Isoldi, MC | 1 |
Pereira, EA | 1 |
Visconti, MA | 1 |
Castrucci, AM | 1 |
Krasagakis, K | 1 |
Lindschau, C | 1 |
Fimmel, S | 1 |
Eberle, J | 1 |
Quass, P | 1 |
Haller, H | 1 |
Orfanos, CE | 1 |
Carsberg, CJ | 1 |
Warenius, HM | 1 |
Friedmann, PS | 1 |
3 other studies available for ro 31-8220 and Malignant Melanoma
Article | Year |
---|---|
The role of calcium, calcium-activated K+ channels, and tyrosine/kinase in psoralen-evoked responses in human melanoma cells.
Topics: Humans; Indoles; Melanoma; Methoxsalen; Photosensitizing Agents; Potassium Channels, Calcium-Activat | 2004 |
Proliferation of human melanoma cells is under tight control of protein kinase C alpha.
Topics: Cell Division; Cell Line, Tumor; Enzyme Inhibitors; Fluorescent Antibody Technique; Humans; Indoles; | 2004 |
Ultraviolet radiation-induced melanogenesis in human melanocytes. Effects of modulating protein kinase C.
Topics: 1-Methyl-3-isobutylxanthine; 3T3 Cells; Animals; Diglycerides; Enzyme Induction; Humans; Indoles; In | 1994 |